|
|
Article: 3M Health Care's Aldara receives EMA approval.(Brief Article)
- Article from:
- Pharma Marketletter
- Article date:
- November 29, 2004
CopyrightCOPYRIGHT 2004 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
3M Health Care says that the European Medicines Agency has cleared its topical response modifier Aldara (imiquimod) cream 5% for the treatment of superficial basal cell carcinoma in adults, marking the first such agent to be approved for this condition. The approval was based on the results from two double-blind, randomized, vehicle-controlled clinical trials involving 364 patients with a single BCC, treated with Aldara or placebo five times a week for six weeks. ...
Related newspaper, magazine, and journal articles:
|
|
Article: Questions being asked on remit of new Italian medicines ...
Pharma Marketletter;
December 8, 2003 ;
700+ words
... ... proposing the creation of a new national medicines agency in Italy is causing a huge amount of ... Mr Addis said, adding: "I think health care professionals, who are starting to ... government intends to form the national medicines agency, but we are very much in favor of ...
|
|